Global Intravenous Immunoglobulin Market Report 2024

Intravenous Immunoglobulin Global Market Report 2024 – By Type( IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels ), By Application( Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications ), By End-User( Hospitals, Clinics, Home Care) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Intravenous Immunoglobulin Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Intravenous Immunoglobulin Market Definition And Segments

Intravenous immunoglobulin refers to a therapy used for the treatment of immunodeficient people. It is administered in the form of intravenous infusion. Infusion liquid is made from immunoglobulins collected from healthy individuals and purified to eliminate any blood-borne infection or impurity.

The main types of intravenous immunoglobulin are Immunoglobulin G (IgE), Immunoglobulin M (IgM), Immunoglobulin A (IgA), (Immunoglobulin E (IgE), Immunoglobulin D (IgD). Immunoglobulin G refers to the most common immunoglobulin found in blood and other body fluids and defends the body against bacterial and viral infection. IgG is used to boost the body’s natural defense system. These are distributed through hospital pharmacy, retail pharmacy, and others, used in applications such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), primary immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, and others. The various end-users include hospitals, clinics, and home care.

The intravenous immunoglobulin market covered in this report is segmented –

1) By Type: Immunoglobulin G (IgE), Immunoglobulin M (IgM), Immunoglobulin A (IgA), (Immunoglobulin E (IgE), Immunoglobulin D (IgD)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

The intravenous immunoglobulin market size has grown strongly in recent years. It will grow from $13.82 billion in 2023 to $14.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to treatment of primary immunodeficiency disorders, management of neurological disorders, rising geriatric population, advancements in plasma fractionation techniques, expanded indications in neurology, treatment of infectious diseases, pediatric immunodeficiency treatment.

The intravenous immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $20.24 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing incidence of autoimmune disorders, ongoing research in immunology, rising healthcare expenditure, growth in cancer incidence, innovation in immunoglobulin products, personalized medicine approaches. Major trends in the forecast period include primary immunodeficiency disorders (PIDD) treatment, rapid technological innovations, strategic collaborations and partnerships, advancements in manufacturing processes, indications in neurology, use in hematology, advances in immunotherapy.

Rising Geriatric Population Fuels Growth In The Intravenous Immunoglobulin Market

The increasing geriatric population is expected to drive the intravenous immunoglobulin market forward. The geriatric population refers to the population above 65 years of age. As people grow old, their immunity does not work properly and there is a lack of antibodies. Therefore, they need immunoglobulins to provide them with antibodies. This increases demand for intravenous immunoglobulins and drives the intravenous immunoglobulin market forward. For instance, in 2021, according to the Elderly in India 2021 report by the National Statistical Office (NSO), a statistics wing of the Ministry of Statistics and Programme Implementation of the government of India, in 2021, 138 million elderly people were there in India and the number is expected to rise to 194 million by 2031. Additionally, according to the World Health Organization (WHO), a specialized agency of the United Nations, by 2030, 1 in 6 people in the world will be 60 years or older and the total number of people over 60 years will increase to 1.4 billion by 2030 increasing from 1 billion in 2020. As a result, the increasing geriatric population will drive the growth of the intravenous immunoglobulin market forward.

Surging Rheumatoid Arthritis Cases Propel Intravenous Immunoglobulin (IVIG) Market Growth

The increasing prevalence of rheumatoid arthritis is expected to propel the growth of the intravenous immunoglobulin (IVIG) market going forward. Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation, pain, swelling, and stiffness in the joints. It is a long-term condition that can lead to joint damage and disability if left untreated. IVIG is a blood product that contains antibodies from healthy donors. These antibodies can help to block the inflammatory process that leads to joint damage in RA. For instance, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 456,000 Australians (1.9%) will have rheumatoid arthritis. RA accounted for 2.0% of the total disease burden and 16% of the total burden of disease due to musculoskeletal conditions in 2022. Furthermore, in July 2022, according to the National Rheumatoid Arthritis Society (NRAS), a UK-based non-profit organization, it was estimated that more than 450,000 people in the UK have rheumatoid arthritis. The most common age for people to develop RA is between 40 and 60, or a bit older for men. Therefore, the increasing prevalence of rheumatoid arthritis is driving the growth of the intravenous immunoglobulin (IVIG) market.

Major companies operating in the intravenous immunoglobulin market report are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bayer AG, LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., Emergent BioSolutions Inc., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

Innovative Human Plasma-Derived Ivig Products Drive Advancements In The Intravenous Immunoglobulin Market

Product innovation is a key trend gaining popularity in the intravenous immunoglobulin market. Major companies in the market are focusing on innovating new products such as human plasma-derived intravenous immunoglobulin (IVIg) for the treatment of rare diseases and sustaining their position in the market. For instance, in June 2021, Octapharma, a Swiss pharmaceutical company, announced that its new product ‘Octagam 10%’, a human plasma-derived intravenous immunoglobulin (IVIg) was granted approval by the European Union (EU) as immunotherapy for adults with dermatomyositis, and national approval by Germany for the same indication. Octagam 10% is the first therapy to be approved for dermatomyositis in the EU and indicated for adults with active dermatomyositis treated with immunosuppressive drugs. This innovative product will help improve the lives of people with dermatomyositis, which is a rare, idiopathic autoimmune disorder.

Increasing Focus On Setting Innovative Standard In The Intravenous Immunoglobulin Market

Major companies operating in the intravenous immunoglobin market are focused on introducing innovative products, such as PANZYGA, and getting them approved by federal agencies, including the US-FDA, to gain a competitive edge in the market. The introduction of an FDA-approved innovative IVIG solution signifies the approval of a novel intravenous immunoglobulin (IVIG) therapy by the U.S. Food and Drug Administration for the treatment of specific medical conditions. For instance, in February 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, announced the U.S. Food and Drug Administration (FDA) approval of PANZYGA for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). It was the first FDA-approved intravenous immunoglobulin with two maintenance dosing options for CIDP. It is caused by damage to the covering of the nerves, called myelin. The authorization of this new indication with additional dosing options helps meet an unmet patient’s need by giving healthcare professionals the option to select an approved dose that is suitable for patients. The approval for this new indication was based on data from prospective, double-blind, multi-center, randomized Phase 3 research including 142 individuals with CIDP. The symptoms of CIDP, an uncommon illness of the peripheral nerves, include weakness linked to the loss of deep tendon reflexes and a progressive loss of symmetry in motor and sensory function.

Grifols Enhances Research And Innovation Strategy With Acquisition Of Gigagen Inc.

In March 2021, Grifols SA, a Spanish pharmaceutical and chemical manufacturer acquired GigaGen Inc for $115 million. The acquisition was completed in two stages; in the first stage, Grifols bought a 44% stake for $35 million and in the second stage, it bought the remaining 56% share for $80 million. The acquisition is in line with Grifols’ R+D+I (research, development, and innovation) strategy to boost innovation and perform research that compliments its core operations. GigaGen is a US-based biotechnology company specializing in the development and discovery of recombinant biotherapeutic medicines.

North America was the largest region in the intravenous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous immunoglobulin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous immunoglobulin market consists of sales of intravenous immunoglobulin used for treating people with antibody deficiencies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The intravenous immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides intravenous immunoglobulin market statistics, including intravenous immunoglobulin industry global market size, regional shares, competitors with an intravenous immunoglobulin market share, detailed intravenous immunoglobulin market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous immunoglobulin industry. This intravenous immunoglobulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Intravenous Immunoglobulin Market Characteristics

    3. Intravenous Immunoglobulin Market Trends And Strategies

    4. Intravenous Immunoglobulin Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Intravenous Immunoglobulin Market Size and Growth

    5.1. Global Intravenous Immunoglobulin Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Intravenous Immunoglobulin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Intravenous Immunoglobulin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Intravenous Immunoglobulin Market Segmentation

    6.1. Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    IgG (Immunoglobulin G)

    IgM (Immunoglobulin M)

    IgA (Immunoglobulin A)

    IgE (Immunoglobulin E)

    IgD (Immunoglobulin D)

    6.2. Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Other Distribution Channels  

    6.3. Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hypogammaglobulinemia

    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Primary Immunodeficiency Diseases

    Myasthenia Gravis

    Multifocal Motor Neuropathy

    Other Applications  

    6.4. Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Clinics

    Home Care

    7. Intravenous Immunoglobulin Market Regional And Country Analysis

    7.1. Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Intravenous Immunoglobulin Market  

    8.1. Asia-Pacific Intravenous Immunoglobulin Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Intravenous Immunoglobulin Market  

    9.1. China Intravenous Immunoglobulin Market Overview  

    9.2. China Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Intravenous Immunoglobulin Market  

    10.1. India Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Intravenous Immunoglobulin Market  

    11.1. Japan Intravenous Immunoglobulin Market Overview  

    11.2. Japan Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Intravenous Immunoglobulin Market  

    12.1. Australia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Intravenous Immunoglobulin Market  

    13.1. Indonesia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Intravenous Immunoglobulin Market  

    14.1. South Korea Intravenous Immunoglobulin Market Overview  

    14.2. South Korea Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Intravenous Immunoglobulin Market  

    15.1. Western Europe Intravenous Immunoglobulin Market Overview

    15.2. Western Europe Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Intravenous Immunoglobulin Market  

    16.1. UK Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Intravenous Immunoglobulin Market  

    17.1. Germany Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Intravenous Immunoglobulin Market  

    18.5. France Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Intravenous Immunoglobulin Market  

    19.9. Italy Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Intravenous Immunoglobulin Market  

    20.13. Spain Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Intravenous Immunoglobulin Market  

    21.1. Eastern Europe Intravenous Immunoglobulin Market Overview

    21.2. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Intravenous Immunoglobulin Market  

    22.1. Russia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Intravenous Immunoglobulin Market  

    23.1. North America Intravenous Immunoglobulin Market Overview

    23.2. North America Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Intravenous Immunoglobulin Market  

    24.1. USA Intravenous Immunoglobulin Market Overview

    24.2. USA Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Intravenous Immunoglobulin Market  

    25.1. Canada Intravenous Immunoglobulin Market Overview

    25.2. Canada Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Intravenous Immunoglobulin Market  

    26.1. South America Intravenous Immunoglobulin Market Overview

    26.2. South America Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Intravenous Immunoglobulin Market  

    27.1. Brazil Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Intravenous Immunoglobulin Market  

    28.1. Middle East Intravenous Immunoglobulin Market Overview

    28.2. Middle East Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Intravenous Immunoglobulin Market  

    29.1. Africa Intravenous Immunoglobulin Market Overview

    29.2. Africa Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Intravenous Immunoglobulin Market Competitive Landscape And Company Profiles

    30.1. Intravenous Immunoglobulin Market Competitive Landscape

    30.2. Intravenous Immunoglobulin Market Company Profiles

    30.2.1. Bio Products Laboratory Limited

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Biotest AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. China Biologic Products Holdings Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. CSL Behring

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Grifols S.A.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Intravenous Immunoglobulin Market Competitive Benchmarking

    32. Global Intravenous Immunoglobulin Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market

    34. Intravenous Immunoglobulin Market Future Outlook and Potential Analysis

    34.1 Intravenous Immunoglobulin Market In 2028 - Countries Offering Most New Opportunities

    34.2 Intravenous Immunoglobulin Market In 2028 - Segments Offering Most New Opportunities

    34.3 Intravenous Immunoglobulin Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Bio Products Laboratory Limited Financial Performance
  • Table 76: Biotest AG Financial Performance
  • Table 77: China Biologic Products Holdings Inc. Financial Performance
  • Table 78: CSL Behring Financial Performance
  • Table 79: Grifols S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Bio Products Laboratory Limited Financial Performance
  • Figure 76: Biotest AG Financial Performance
  • Figure 77: China Biologic Products Holdings Inc. Financial Performance
  • Figure 78: CSL Behring Financial Performance
  • Figure 79: Grifols S.A. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the in-vitro toxicology testing market?

In-vitro toxicology testing refers to assays and tests used to determine toxic doses of drugs, nutraceuticals, and food additives that cause toxicity when administered. It is used to detect the presence of toxic chemicals, and residual solvents and reduce hazardous exposure. This testing is mostly used to determine the doses of medications that exhibit toxicity in preclinical development, along with drug discovery and development. For further insights on the in-vitro toxicology testing market, request a sample here

How will the in-vitro toxicology testing market drivers and restraints affect the in-vitro toxicology testing market dynamics? What forces will shape the in-vitro toxicology testing industry going forward?

The in-vitro toxicology testing market major growth driver - growing healthcare expenditure fuels in-vitro toxicology testing market growth. For further insights on the in-vitro toxicology testing market, request a sample here

What is the forecast market size or the forecast market value of the in-vitro toxicology testing market ?

The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $10.31 billion in 2023 to $11.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to regulatory requirements, ethical concerns and animal welfare, cost and time efficiency, globalization of the pharmaceutical industry, drug discovery and development demands, public awareness of environmental toxins. The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to focus on personalized medicine, demand for predictive toxicology models, expansion of environmental testing, oncology drug development challenges, focus on endocrine disruptor screening, shift towards multi-organ chips. Major trends in the forecast period include advancements in 3d cell culture technologies, integration of high-throughput screening, focus on organ-on-a-chip technologies, application in chemical safety assessment, use of human-derived cell lines, incorporation of omics technologies, educational initiatives and training programs. For further insights on the in-vitro toxicology testing market, request a sample here

How is the in-vitro toxicology testing market segmented?

The in-vitro toxicology testing market is segmentedThe in-vitro toxicology testing market covered in this report is segmented –
1) By Product and Service: Consumables, Assays, Equipment, Software, Services
2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models
3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics
4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications
5) By Industry: Pharmaceuticals and Biopharmaceuticals, Cosmetic and Household Products, Food, ChemicalsFor further insights on the in-vitro toxicology testing market,
request a sample here

Which region has the largest share of the in-vitro toxicology testing market? What are the other regions covered in the report?

North America was the largest region in the in- vitro toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the in-vitro toxicology testing market, request a sample here.

Who are the major players in the in-vitro toxicology testing market?

Major companies operating in the in-vitro toxicology testing market report are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Abbott Laboratories, Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Quest Diagnostics Incorporated, Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation For further insights on the in-vitro toxicology testing market, request a sample here.

What are the key trends in the in-vitro toxicology testing market?

Major trend in the in-vitro toxicology testing market - technological advancement drives growth in the in-vitro toxicology testing market. For further insights on the in-vitro toxicology testing market, request a sample here.

What are the major opportunities in the in-vitro toxicology testing market? What are the strategies for the in-vitro toxicology testing market?

For detailed insights on the major opportunities and strategies in the in-vitro toxicology testing market, request a sample here.

How does the in-vitro toxicology testing market relate to the overall economy and other similar markets?

For detailed insights on in-vitro toxicology testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the in-vitro toxicology testing industry?

For detailed insights on the mergers and acquisitions in the in-vitro toxicology testing industry, request a sample here.

What are the key dynamics influencing the in-vitro toxicology testing market growth? SWOT analysis of the in-vitro toxicology testing market.

For detailed insights on the key dynamics influencing the in-vitro toxicology testing market growth and SWOT analysis of the in-vitro toxicology testing industry, request a sample here.